Synaffix BV

[Available On-Demand] ・ Click video to start playback; Join chat Q&A below video
Search General Info
We have a clinical-stage platform technology to generate best-in-class ADCs which is validated by >$420m in deals across 3 partnerships. Our business model is technology out-licensing.
Company Type:
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Netherlands
Year Founded:
2010
Main Therapeutic Focus:
Lead Product in Development:
No Synaffix pipeline / only technology out-licensing
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Director, Business Development
Synaffix BV